Fork detected. Volatility imminent.
A Chinese insurance tech company just used Bitcoin—not dollars—as payment for equity. Zhibao Technology Inc., headquartered in Shanghai, closed a private investment in public equity (PIPE) on August 17, 2024, where investors delivered 2,380 BTC as consideration for shares and warrants. The reference price: $65,000 per Bitcoin, valuing the deal at $154.7 million. This is not a DeFi protocol upgrade. It is a financial engineering fork that rewrites corporate treasury rules.
Context: Why This Matters Now
The trend of public companies adding Bitcoin to their balance sheets has been dominated by MicroStrategy’s debt-and-buy model. But Zhibao’s approach is structurally different. Instead of raising cash to buy Bitcoin, they issued equity directly in exchange for the crypto. The PIPE (Private Investment in Public Equity) structure is common in distressed or growth-stage companies, but using Bitcoin as payment is rare. The SEC filing (Form 6-K) confirms the transaction, but the details reveal a complex web of dilution, hidden risks, and a significant reduction in scale from an initial target of 3,500 BTC. This is a test case for how traditional companies can adopt Bitcoin without relying on the cash market—and it exposes critical gaps in disclosure.
Core: The Deal’s Anatomy and Hidden Fault Lines
Let’s dissect the mechanics. Zhibao issued 442 million PIPE units at $0.35 per unit. Each unit consists of one share of Class A common stock and one warrant exercisable at $0.35 for two years. Of these, 395,678,152 units were immediately delivered; the remaining 46,321,848 units await shareholder approval to increase authorized share capital. The investors paid 2,380 BTC, which were transferred to a company-designated wallet. No custody details, no private key management disclosure, no independent audit. This is a major information gap.
Based on my experience auditing EigenLayer’s slasher contract in 2023, I know that the absence of security documentation is a red flag. For a company holding $150 million in a volatile, self-custodied asset, the lack of details on cold storage, multi-signature, or third-party custody is irresponsible. The shareholders—and the SEC—should demand answers.
Now, the dilution math. The fully diluted share count from this PIPE alone is at least 442 million shares, plus potential warrants. Assuming Zhibao’s pre-deal shares were small (a typical micro-cap), the dilution could be brutal. The 46 million pending shares are even more problematic: they require no additional payment from investors. They are essentially free equity waiting for a vote. If approved, existing shareholders face a 10% dilution without any new capital inflow.
The reduction from 3,500 to 2,380 BTC is another negative signal. A 32% cut suggests either insufficient investor demand, a price disagreement, or due diligence issues. In the 2022 Terra/Luna collapse, I learned that funding reductions often precede deeper problems. Investors should ask: why did the original commitment shrink?
Data-Driven Insight: The Price Arbitrage
The reference price of $65,000 per Bitcoin is crucial. At the time of the deal’s negotiation (likely late July 2024), Bitcoin traded around $65,000-$67,000. But by the August 17 closing, Bitcoin had dropped to approximately $58,000-$62,000. If so, the investors delivered 2,380 BTC worth roughly $58 million less than the reference value. They effectively bought Zhibao shares at a discount to the stated deal price. The company’s balance sheet now shows a $154.7 million asset, but the market value of that asset may be lower. This accounting mismatch will require impairment testing under IFRS or GAAP, and could lead to write-downs if Bitcoin falls further.
Contrarian: The Unreported Angle – This Is Not a Vote of Confidence
Mainstream crypto media will frame this as a bullish signal: “Another company adds Bitcoin to treasury.” But the contrarian truth is that the PIPE investors are sophisticated. They swapped Bitcoin (a highly liquid, volatile asset) for illiquid, heavily diluted equity in a small insurance tech company. Why? Because they believe the stock’s potential upside exceeds Bitcoin’s—or they want to offload Bitcoin at a premium. The warrants give them a second potential payout if the stock rises. This is a hedge, not a conviction.
Furthermore, the Chinese regulatory backdrop is hostile to crypto. Zhibao’s Shanghai headquarters operates under the People’s Bank of China’s strict anti-crypto stance. If the company holds Bitcoin on its balance sheet, it may violate Chinese regulations. The use of an offshore US-listed entity could mitigate this, but it creates a compliance gray zone. The SEC’s Form 6-K disclosure does not address this. The risk of a regulatory crackdown is non-zero.
Audit passed, but logic flawed. The deal’s structure appears compliant: SEC filing, PIPE exemption, standard terms. But the logic of using Bitcoin as payment is flawed if the company’s core business (insurance tech) has no synergy with crypto. Unlike MicroStrategy, which treats Bitcoin as a primary treasury asset, Zhibao’s move looks like a desperate attempt to raise capital in a bear market. The 32% reduction in size suggests the market was not enthusiastic.
Takeaway: What to Watch Next
The next critical event is the shareholder vote to authorize additional shares. If approved, the dilution will be locked in. Monitor the BTC price relative to $65,000. If Bitcoin drops below $50,000, Zhibao’s balance sheet will suffer, and the stock could plummet. Also watch for further SEC inquiries on custody and valuation methodology. The company’s 6-K filing is a start, but it lacks the depth required for a $150 million crypto asset.
This is not a trend to follow blindly. It’s a case study in how traditional finance can misapply crypto. The smart money is already hedging. Are you?
Mempool congestion hit record highs. The number of unanswered questions is piling up. Fork detected. Volatility imminent.